11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer

F Ceci, P Castellucci, T Graziani… - Clinical nuclear …, 2015 - journals.lww.com
Aim The aim of this study was to compare 11 C-choline PET/CT, prostate-specific antigen
(PSA), PSA kinetics, and 11 C-choline uptake in recurrent metastatic prostate cancer …

[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy

M Picchio, EG Spinapolice, F Fallanca… - European journal of …, 2012 - Springer
Purpose The aim of this study was to evaluate the clinical usefulness of [11 C] choline
positron emission tomography (PET)/CT in comparison with bone scintigraphy (BS) in …

[HTML][HTML] Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

W Huysse, F Lecouvet, P Castellucci, P Ost… - Diagnostics, 2017 - mdpi.com
We compared fluor-18 choline positron emission tomography/computed tomography
(PET/CT) and axial skeleton magnetic resonance imaging (MRI) prospectively obtained for …

Diagnostic performance of bone scintigraphy and 11C-choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer

JR Garcia, C Moreno, E Valls, P Cozar, P Bassa… - Revista Española de …, 2015 - Elsevier
Aim To compare bone scan (BS) with 11 C-choline PET/CT for the detection of bone
metastases in patients with biochemical recurrence of prostate cancer (PC). Materials and …

Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy

C Fuccio, P Castellucci, R Schiavina… - European journal of …, 2012 - Elsevier
AIM: to evaluate the utility of 11C-choline PET/CT in prostate cancer (PC) patients who have
demonstrated a biochemical recurrence and a negative bone scintigraphy (BS) …

Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy

C Fuccio, P Castellucci, R Schiavina, I Santi… - Annals of nuclear …, 2010 - Springer
Aim To assess the utility of 11 C-choline PET/CT in the restaging of prostate cancer (PC)
patients who showed a single finding on bone scintigraphy (BS) that was classified as …

[11C] Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer

M Tuncel, M Souvatzoglou, K Herrmann… - Nuclear medicine and …, 2008 - Elsevier
INTRODUCTION: To evaluate [11C] Choline positron emission tomography (PET)/computed
tomography (CT) for staging and restaging of patients with advanced prostate cancer and to …

C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy

YY Evan, M Muzi, JA Hackenbracht… - Clinical nuclear …, 2011 - journals.lww.com
Materials and Methods: Men with≥ 3 prostate cancer bone metastases identified by Tc-99m
methylene diphosphonate (MDP) bone scintigraphy and/or computed tomography were …

Detection of bone metastases using 11C-acetate PET in patients with prostate cancer with biochemical recurrence

C Spick, SH Polanec, M Mitterhauser… - Anticancer …, 2015 - ar.iiarjournals.org
Aim: To evaluate the diagnostic accuracy of 11C-acetate positron-emission tomography
(PET) in the detection of bone metastasis in patients with prostate cancer with biochemical …

Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis

G Shen, H Deng, S Hu, Z Jia - Skeletal radiology, 2014 - Springer
Published data on the diagnosis of bone metastases of prostate cancer are conflicting and
heterogeneous. We performed a comprehensive meta-analysis to compare the diagnostic …